Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers.

Liu L, Tang Y, Gao C, Li Y, Chen S, Xiong T, Li J, Du M, Gong Z, Chen H, Liu L, Yao P.

Colloids Surf B Biointerfaces. 2014 Mar 1;115:125-31. doi: 10.1016/j.colsurfb.2013.11.029. Epub 2013 Nov 24.

PMID:
24333909
2.

Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro-in vivo advantage.

Jain AS, Shah SM, Nagarsenker MS, Nikam Y, Gude RP, Steiniger F, Thamm J, Fahr A.

J Biomed Nanotechnol. 2013 Jul;9(7):1230-40.

PMID:
23909137
3.

Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.

Luan J, Zhang D, Hao L, Qi L, Liu X, Guo H, Li C, Guo Y, Li T, Zhang Q, Zhai G.

Colloids Surf B Biointerfaces. 2014 Feb 1;114:255-60. doi: 10.1016/j.colsurfb.2013.10.018. Epub 2013 Oct 19.

PMID:
24211416
4.

Nanostructured lipid carriers as a delivery system of biochanin A.

Wang Q, Cheng H, Zhou K, Wang L, Dong S, Wang D, Chen W.

Drug Deliv. 2013 Nov;20(8):331-7. doi: 10.3109/10717544.2013.838716.

PMID:
24111887
5.

Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.

Chen-yu G, Chun-fen Y, Qi-lu L, Qi T, Yan-wei X, Wei-na L, Guang-xi Z.

Int J Pharm. 2012 Jul 1;430(1-2):292-8. doi: 10.1016/j.ijpharm.2012.03.042. Epub 2012 Apr 1.

PMID:
22486962
6.

Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.

Jia L, Zhang D, Li Z, Duan C, Wang Y, Feng F, Wang F, Liu Y, Zhang Q.

Colloids Surf B Biointerfaces. 2010 Oct 15;80(2):213-8. doi: 10.1016/j.colsurfb.2010.06.008. Epub 2010 Jun 23.

PMID:
20621458
7.

Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.

Ranpise NS, Korabu SS, Ghodake VN.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:81-7. doi: 10.1016/j.colsurfb.2013.12.012. Epub 2013 Dec 30.

PMID:
24445002
8.

In vivo studies on the oridonin-loaded nanostructured lipid carriers.

Zheng D, Dai W, Zhang D, Duan C, Jia L, Liu Y, Zhang Q.

Drug Deliv. 2012 Aug;19(6):286-91. doi: 10.3109/10717544.2012.704096. Epub 2012 Aug 28.

PMID:
22928767
9.

Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.

Liu X, Zhang Z, Jiang Y, Hu Y, Wang Z, Liu J, Feng R, Zhang J, Huang G.

Drug Deliv. 2015 Feb;22(2):223-9. doi: 10.3109/10717544.2014.885614. Epub 2014 Feb 21.

PMID:
24559497
10.

Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.

Dai W, Zhang D, Duan C, Jia L, Wang Y, Feng F, Zhang Q.

J Microencapsul. 2010 May;27(3):234-41. doi: 10.3109/02652040903079526.

PMID:
20113167
11.

Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.

Song X, Lin Q, Guo L, Fu Y, Han J, Ke H, Sun X, Gong T, Zhang Z.

Pharm Res. 2015 May;32(5):1741-51. doi: 10.1007/s11095-014-1572-3. Epub 2014 Nov 19.

PMID:
25407545
12.

Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.

Hsu SH, Wen CJ, Al-Suwayeh SA, Chang HW, Yen TC, Fang JY.

Nanotechnology. 2010 Oct 8;21(40):405101. doi: 10.1088/0957-4484/21/40/405101. Epub 2010 Sep 8.

PMID:
20823498
13.

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

Shangguan M, Lu Y, Qi J, Han J, Tian Z, Xie Y, Hu F, Yuan H, Wu W.

J Biomater Appl. 2014 Feb;28(6):887-96. doi: 10.1177/0885328213485141. Epub 2013 Sep 5.

PMID:
24008629
14.

Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.

Gabal YM, Kamel AO, Sammour OA, Elshafeey AH.

Int J Pharm. 2014 Oct 1;473(1-2):442-57. doi: 10.1016/j.ijpharm.2014.07.025. Epub 2014 Jul 22.

PMID:
25062866
15.

Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.

Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H.

J Control Release. 2009 Feb 10;133(3):238-44. doi: 10.1016/j.jconrel.2008.10.002. Epub 2008 Oct 12.

PMID:
18951932
16.

Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.

Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y.

Expert Opin Drug Deliv. 2015 Feb;12(2):181-94. doi: 10.1517/17425247.2014.945416. Epub 2014 Aug 28.

PMID:
25164097
17.

Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration.

Date AA, Nagarsenker MS, Patere S, Dhawan V, Gude RP, Hassan PA, Aswal V, Steiniger F, Thamm J, Fahr A.

Mol Pharm. 2011 Jun 6;8(3):716-26. doi: 10.1021/mp100305h. Epub 2011 Apr 20.

PMID:
21480639
18.

A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.

Lin C, Chen F, Ye T, Zhang L, Zhang W, Liu D, Xiong W, Yang X, Pan W.

Int J Pharm. 2014 Apr 25;465(1-2):90-6. doi: 10.1016/j.ijpharm.2014.02.013. Epub 2014 Feb 12.

PMID:
24530388
19.

In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.

Jia L, Shen J, Zhang D, Duan C, Liu G, Zheng D, Tian X, Liu Y, Zhang Q.

Int J Biol Macromol. 2012 Apr 1;50(3):523-9. doi: 10.1016/j.ijbiomac.2012.01.024. Epub 2012 Jan 24.

PMID:
22301003
20.

Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.

Elnaggar YS, El-Massik MA, Abdallah OY.

Int J Nanomedicine. 2011;6:3195-205. doi: 10.2147/IJN.S25825. Epub 2011 Dec 6.

Supplemental Content

Support Center